Home > National Drug Code (NDC) > CANDIDA MONILA ALBICANS

CANDIDA MONILA ALBICANS - 54575-188-02 - (candida albicans)

Alphabetical Index


Drug Information of CANDIDA MONILA ALBICANS

Product NDC: 54575-188
Proprietary Name: CANDIDA MONILA ALBICANS
Non Proprietary Name: candida albicans
Active Ingredient(s): 1    g/20mL & nbsp;   candida albicans
Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of CANDIDA MONILA ALBICANS

Product NDC: 54575-188
Labeler Name: Allergy Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA101376
Marketing Category: BLA
Start Marketing Date: 19671207

Package Information of CANDIDA MONILA ALBICANS

Package NDC: 54575-188-02
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (54575-188-02)

NDC Information of CANDIDA MONILA ALBICANS

NDC Code 54575-188-02
Proprietary Name CANDIDA MONILA ALBICANS
Package Description 2 mL in 1 VIAL, MULTI-DOSE (54575-188-02)
Product NDC 54575-188
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name candida albicans
Dosage Form Name INJECTION, SOLUTION
Route Name PERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date 19671207
Marketing Category Name BLA
Labeler Name Allergy Laboratories, Inc.
Substance Name CANDIDA ALBICANS
Strength Number 1
Strength Unit g/20mL
Pharmaceutical Classes Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE]

Complete Information of CANDIDA MONILA ALBICANS


General Information